The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[5-{1-(4-tolyl)imidazo[1,5-a]pyridin-3-yl}furan-2-yl]methanol ID: ALA3946046
PubChem CID: 134147044
Max Phase: Preclinical
Molecular Formula: C19H16N2O2
Molecular Weight: 304.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2nc(-c3ccc(CO)o3)n3ccccc23)cc1
Standard InChI: InChI=1S/C19H16N2O2/c1-13-5-7-14(8-6-13)18-16-4-2-3-11-21(16)19(20-18)17-10-9-15(12-22)23-17/h2-11,22H,12H2,1H3
Standard InChI Key: REGPEUJVJXAKMB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
25.0151 -8.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9271 -9.1153 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3516 -7.0076 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3518 -7.8248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5746 -8.0754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0943 -7.4164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5744 -6.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5464 -4.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8372 -4.4997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1282 -4.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1283 -5.7256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8374 -6.1341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5465 -5.7254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3237 -5.9758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8038 -5.3166 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3235 -4.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5740 -3.8762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3731 -3.7063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6236 -2.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0755 -2.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2736 -2.4986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0267 -3.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3251 -1.5453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
3 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
8 13 1 0
14 15 2 0
15 16 1 0
13 14 1 0
8 16 2 0
16 17 1 0
7 14 1 0
1 4 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.35Molecular Weight (Monoisotopic): 304.1212AlogP: 4.06#Rotatable Bonds: 3Polar Surface Area: 50.67Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.70CX Basic pKa: 4.69CX LogP: 3.20CX LogD: 3.19Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.62Np Likeness Score: -0.89
References 1. Fuse S, Ohuchi T, Asawa Y, Sato S, Nakamura H.. (2016) Development of 1-aryl-3-furanyl/thienyl-imidazopyridine templates for inhibitors against hypoxia inducible factor (HIF)-1 transcriptional activity., 26 (24): [PMID:27847273 ] [10.1016/j.bmcl.2016.11.009 ]